Malacañang on Friday told former president Rodrigo Duterte’s domestic partner, Honeylet Avanceña, not to make fun of the ...

Many of us who followed the avalanche of difficult questioning by Supreme Court Associate Justices Amy Lazaro-Javier of the solicitor general, the government corporate counsel, and its senior vice ...

2025年4月，国家药品监督管理局（NMPA）正式批准信玖凝®上市，这是亚洲首款、全球第三款血友病B基因治疗药物。从实验室到临床，从“终身输注”到“一针治愈”，在历时了6年的临床研究阶段，已经改写众多患者的命运，也将为更多患者带来新的生命起点。

Union Health Minister J P Nadda on Friday launched the Ayushman Bharat scheme in Odisha. He also launched the Ayushman ...

The gene therapy BBM-H901 (dalnacogene ponparvovec) has been approved in China for adults with moderate to severe hemophilia ...

Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

China has approved its first gene therapy for hemophilia B, an inherited bleeding disorder caused by the deficiency of ...

4月10日，信念医药与武田中国共同宣布，信玖凝（BBM-H901注射液，通用名称：波哌达可基注射液）已正式获得国家药品监督管理局（NMPA）批准，用于中重度血友病B（先天性凝血因子IX缺乏症）成年患者的治疗。信念医药表示，信玖凝由公司研发生产，武田中国负责该产品在国内的商业化进程。双方将整合各自资源优势，加速为患者提供突破性的基因疗法，共同开拓血友病B治疗领域新格局。

BBM-H901 ...

Belief BioMed and Takeda China today jointly announced that BBM-H901, has been officially approved by the National Medical ...

An alleged drug peddler was injured in an encounter with the police in Bhubaneswar, an officer said on Friday. The incident took place in Khandagiri area in the intervening night of Thursday and ...

一个新的先进疗法时代，正被一家本土Biotech洞开。